Influence of Hygiene-dietetic Habits and Treatment Adherence on the Effectiveness of the Gastroesophageal Reflux Illness Treatment With Rabeprazol
NCT00511966 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1049
Last updated 2011-05-19
Summary
The objective of this Observational study is to evaluate hygiene-dietetic habits as co-adjuvant treatment of the pharmacologic therapy use to treat Gastroesophageal Reflux.
Conditions
- Gastroesophageal Reflux
Interventions
- OTHER
-
Non-Pharmacologic Treatment
Non-Pharmacologic Treatment
- DRUG
-
Rabeprazole
As prescribed
Sponsors & Collaborators
-
Janssen-Cilag, S.A.
lead INDUSTRY
Principal Investigators
-
Janssen-Cilag S.A. (formerly Janssen Sp) Clinical Trial · Janssen-Cilag, S.A.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Completion
- 2002-11-30
More Related Trials
-
Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole
NCT00132496 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)
NCT00216489 ·Status: COMPLETED ·Phase: PHASE4
-
Practice and Patient Compliance on the PPI (Proton Pump Inhibitors) Treatment of Gastroesophageal Reflux in South Korea
NCT01018160 ·Status: COMPLETED
-
E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
NCT00236197 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Single and Multiple Doses of Rabeprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive
NCT00747526 ·Status: COMPLETED ·Phase: PHASE1
-
Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)
NCT00222170 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Efficacy and Safety of "On-demand" Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD)
NCT00236392 ·Status: COMPLETED ·Phase: PHASE3
-
What is the Predictive Value of the Reflux Impact Scale
NCT00536328 ·Status: TERMINATED
-
Treatment Response of High-dose and Standard-dose Rabeprazole for Extra-esophageal Reflux.
NCT04001400 ·Status: COMPLETED ·Phase: PHASE3
-
Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux Esophagitis
NCT01321567 ·Status: COMPLETED
-
Maintenance Intermittent Therapy for Symptomatic GERD Patients
NCT00165841 ·Status: COMPLETED ·Phase: PHASE2
-
E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
NCT00236184 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients
NCT00787891 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD)
NCT00992589 ·Status: COMPLETED ·Phase: PHASE3
-
Post-nasal Drainage as an Extraesophageal Manifestation of Reflux
NCT00199953 ·Status: COMPLETED ·Phase: PHASE2
-
A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Years Old, Inclusive
NCT00747695 ·Status: COMPLETED ·Phase: PHASE1
-
Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-adjusted Dosing
NCT00537732 ·Status: TERMINATED ·Phase: PHASE4
-
Double-dose Rabeprazole Accelerates and Sustains the Control of Symptoms in Patients With NERD
NCT01391715 ·Status: WITHDRAWN ·Phase: PHASE3
-
Effects of YF476 and Rabeprazole on Gastric Function
NCT01699113 ·Status: COMPLETED ·Phase: PHASE1
-
Utilization of Anti-reflux Treatment and Course of Illness Leading to Reoperation
NCT03536169 ·Status: COMPLETED
-
Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease.
NCT01601379 ·Status: COMPLETED
-
The Effect of Probiotic and Zinc Supplementation in Patients With Gastroesophageal Reflux Disease
NCT06664008 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Study of E3810 With Pre- and Post-Treatment pH Monitoring in Patients With Non-Erosive Gastroesophageal Reflux Disease
NCT00165672 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.
NCT00214552 ·Status: COMPLETED ·Phase: PHASE3
-
Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression
NCT00234117 ·Status: COMPLETED ·Phase: NA